Chalice Brands Ltd. (OTCPK: CHAL.F)
Health Care · Pharmaceuticals · US
$—
— today · — 1Y
Chalice Brands Ltd. (OTCPK: CHAL.F) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $84.00.
trading between 0.00 and 0.00.
Tweenvest scores Chalice Brands Ltd. across four factors: quality 27/100, value 49/100, growth 100/100. Its strongest factor is growth.
CHAL.F price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $84.00
- Revenue (TTM)
- $25.96M
- P/E
- —
- EPS
- -0.11
- Dividend yield
- —
- Beta (5Y)
- 10.28
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 84.42M
- Employees
- —
- Next earnings
- —
About Chalice Brands Ltd.
Chalice Brands Ltd. engages in the retail, production, processing, wholesale, and distribution of cannabis products. It owns, operates, and manages a network of sixteen retail dispensaries in Oregon, including six operate under the flagship dispensary banner Chalice Farms; five operate under the banner of Homegrown Oregon; four under the banner of Cannabliss and Co; and one under the banner of Left Coast Connections. The company also provides Private Stash distillate vaporizer cartridges and single serve fruit chew blast product under the Golden and Chalice brands, as well as ethanol extract products under the RXO brand name and a live resin and distillate vaporizer cartridge under the brand name of Elysium Fields. In addition, it manufactures and sells oil products under the brand names Chalice, Golden, Private Stash, Elysium Fields, and Jackpot. The company was formerly known as Golden Leaf Holdings Ltd. and changed its name to Chalice Brands Ltd. in May 2021. Chalice Brands Ltd. is based in Toronto, Canada.
- ISIN
- CA15756R1047
- Listed since
- Oct 19, 2015
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,244.86 | -0.17% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $270.41 | -0.96% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $150.93 | +0.18% |
| Roche Holding AGSWX: ROP | $368.80B | CHF370.90 | +0.13% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £121.72 | +0.51% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $27.99 | +0.07% |
Figures last refreshed Aug 18, 2026.